Signs and Symptoms Clinical Trials

7 recruitingLast updated: July 25, 2026

There are 7 actively recruiting signs and symptoms clinical trials across 5 countries. Studies span Not Applicable, Phase 4. Top locations include Baltimore, Maryland, United States, Charleston, West Virginia, United States, Cleveland, Ohio, United States. Updated daily from ClinicalTrials.gov.


Signs and Symptoms Trials at a Glance

7 actively recruiting trials for signs and symptoms are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Baltimore, Charleston, and Cleveland. Lead sponsors running signs and symptoms studies include Johns Hopkins University, Mucosa Innovations, S.L., and Case Comprehensive Cancer Center.

Browse signs and symptoms trials by phase

About Signs and Symptoms Clinical Trials

Looking for clinical trials for Signs and Symptoms? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Signs and Symptoms trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Signs and Symptoms clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions

Arterial Occlusive DiseasesPainCardiovascular Diseases+12 more
Teleflex1,859 enrolled2 locationsNCT07258290
Recruiting

Biomedical Signal Extraction From Symptom Descriptions: An Observational Registry Using the OpenGenome Platform

Skin DiseasesFeverHemorrhagic Fever With Renal Syndrome+3 more
OpenGenome1,000 enrolled1 locationNCT07578610
Recruiting
Not Applicable

Prospective Registry for Long-term Outcomes Following FETO in Severe Left and Right CDH

HerniaCongenital Diaphragmatic HerniaInternal Hernia+5 more
Johns Hopkins University80 enrolled1 locationNCT07166172
Recruiting
Not Applicable

Changes in the Impact of Genitourinary Syndrome of Menopause With a Novel Nonhormonal Vulvovaginal Gel Assessed by PROMs.

Sexual FunctionWomen's healthQuality of Life+7 more
Mucosa Innovations, S.L.80 enrolled1 locationNCT06962345
Recruiting

Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation

Graft vs Host DiseaseVulvovaginal Signs and Symptoms
Case Comprehensive Cancer Center40 enrolled1 locationNCT06649201
Recruiting
Phase 4

Cognitive Outcomes After Dexmedetomidine Sedation in Cardiac Surgery Patients

ConfusionCognitive DysfunctionMolecular Mechanisms of Pharmacological Action+14 more
Sunnybrook Health Sciences Centre2,400 enrolled8 locationsNCT04289142
Recruiting

Evaluation of ocular signs and symptoms following contact lens wear

Ocular signs and symptoms related to contact lens multipurpose solutions and contact lens wear
University of New South Wales80 enrolled1 locationACTRN12618000326291